TIGIT and preeclampsia: We assume that immune checkpoint molecules, including TIGIT/CD226/CD112/CD155, have an essential role in the regulation of the Th1 predominance, which is initiated by intrinsic factors released by the poorly developed placenta during EO preeclampsia.